Bank Of New York Mellon Corp Krystal Biotech, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $5.18 Million - $6.56 Million	82,096 New	82,096 $6.5 Million
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $293,705 - $373,189	4,529 Added 5.64%	84,792 $5.91 Million
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $324,503 - $487,253	-6,632 Reduced 7.63%	80,263 $5.27 Million
Q1 2022 May 11, 2022	BUY	$51.99 - $72.11 $179,053 - $248,346	3,444 Added 4.13%	86,895 $5.78 Million
Q4 2021 Feb 11, 2022	BUY	$39.81 - $88.24 $279,545 - $619,621	7,022 Added 9.19%	83,451 $5.84 Million
Q3 2021 Nov 12, 2021	BUY	$52.01 - $71.77 $301,605 - $416,194	5,799 Added 8.21%	76,429 $3.99 Million
Q2 2021 Aug 11, 2021	BUY	$62.14 - $81.82 $202,700 - $266,896	3,262 Added 4.84%	70,630 $4.8 Million
Q1 2021 May 13, 2021	SELL	$59.42 - $85.46 $6,655 - $9,571	-112 Reduced 0.17%	67,368 $5.19 Million
Q4 2020 Feb 09, 2021	BUY	$40.64 - $61.38 $205,841 - $310,889	5,065 Added 8.12%	67,480 $4.05 Million
Q3 2020 Nov 12, 2020	BUY	$37.76 - $48.49 $132,235 - $169,811	3,502 Added 5.94%	62,415 $2.69 Million
Q2 2020 Aug 12, 2020	SELL	$37.03 - $60.0 $233,548 - $378,420	-6,307 Reduced 9.67%	58,913 $2.44 Million
Q1 2020 May 06, 2020	SELL	$35.02 - $65.64 $82,962 - $155,501	-2,369 Reduced 3.51%	65,220 $2.82 Million
Q4 2019 Feb 14, 2020	SELL	$33.17 - $65.23 $166,745 - $327,911	-5,027 Reduced 6.92%	67,589 $3.74 Million
Q3 2019 Nov 07, 2019	BUY	$34.72 - $51.3 $273,940 - $404,757	7,890 Added 12.19%	72,616 $2.52 Million
Q2 2019 Aug 12, 2019	BUY	$27.2 - $41.2 $1.19 Million - $1.81 Million	43,859 Added 210.18%	64,726 $2.61 Million
Q1 2019 May 14, 2019	SELL	$19.86 - $32.9 $75,666 - $125,349	-3,810 Reduced 15.44%	20,867 $687,000
Q4 2018 Feb 11, 2019	BUY	$15.03 - $25.38 $370,895 - $626,302	24,677 New	24,677 $513,000

Others Institutions Holding KRYS

# of Institutions

311

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

Black Rock Inc. New York, NY

3.95M
Shares

$777 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

2.85M
Shares

$561 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

2.62M
Shares

$516 Million
7.18% of portfolio
State Street Corp Boston, MA

1.45M
Shares

$286 Million
0.01% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

988K
Shares

$195 Million
9.67% of portfolio

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.05B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account